South Korea Computed Tomography Market Size

South Korea Computed Tomography Market Analysis

The South Korea Computed Tomography Market size is estimated at USD 226.64 million in 2024, and is expected to reach USD 308.05 million by 2029, growing at a CAGR of 6.33% during the forecast period (2024-2029).

The COVID-19 pandemic produced significant disruptions in medical care, including hold-ups in clinical studies as well as delays in diagnosis and treatment. The use of computed tomography imaging for the early diagnosis of cancers throughout South Korea was made possible by the fact that all screening locations were functional and that all patients could choose to have their diagnostic screenings. Throughout the pandemic phase, this contributed to the market's expansion. In addition, a study published in the European Journal of Cancer in July 2020 with the title "Innovative countermeasures can sustain cancer care continuity during the coronavirus disease-2019 pandemic in Korea" compared the state of common cancer in 2019 and 2020. According to the article's findings, 1,694 initial cancer diagnoses were made in total in 2019 as opposed to 1,445 in 2020, a decline of 14.7%. The government's innovative countermeasures allowed doctors to treat patients routinely while following accepted infection control guidelines. During the pandemic, these factors significantly affected South Korea's digital imaging practices. As a result, the pandemic adversely impacted digital imaging methods during the initial stages of South Korea's cancer screening programs. Thus, the market was adversely affected by the pandemic, however, the market will grow in the future as the procedures will increase post-pandemic.

The country's market is driven by the rising elderly population as well as local academic research. The population of South Korea has been ageing quickly. In South Korea, the population 65 and older is predicted to increase from 2,376,000 (9.3%) of the total population in 2019 to 5,232,000 (19.7%) of the total population in 2050, according to the World Population Ageing report (2020). Numerous studies have also looked at the use of CT scans to diagnose patients' heart problems. The Korea Initiatives on Coronary Artery Calcification (KOICA) registry study, "Sex variations in coronary artery calcium progression," was released in April 2021. The Korea Initiatives on Coronary Artery Calcification (KOICA) Registry, according to the study, is an observational, retrospective, multicenter registry of Korean people who received coronary artery calcification (CAC) scoring as a part of a health examination. CAC was evaluated using multi-detector CT scanners with at least 16 slices. At the Presbyterian Medical Center in Jeonju, Korea, a study titled "Clinical Usefulness of Contrast-Enhanced Computed Tomography in Patients with Non-Obstructive Acute Pyleonephritis" was published in June 2020. According to the study, individuals with non-obstructive acute pyelonephritis and retained renal function may be able to predict the clinical severity and course using contrast-enhanced computed tomography (CE-CT) scans. Using contrast-enhanced computed tomography (CECT), acute pyelonephritis can be identified. It can offer crucial details on the variety of inflammation and other related issues to aid in making a clear diagnosis. Such investigations are anticipated to accelerate market growth during the anticipated time frame. Such studies are probably going to help the market grow during the anticipated period. Similarly, in October 2020, to promote secure and effective imaging diagnosis, Siemens Healthineers delivered cutting-edge CT and MRI to smile imaging medicine in South Korea.

However, lack of reimbursement and high cost of devices are expected to hinder the market growth.